Boston Scientific Stresses Cardiology R&D, Makes Over Business Units

Boston Scientific's planned launches of IVUS systems, cutting balloons and embolic protection devices will allow the firm to buttress its drug-eluting stent offering with core cardiovascular growth

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Medtech Insight